Effect of topical oral G-CSF on oral mucositis: A randomised placebo-controlled trial

Bone Marrow Transplantation

Volumn 22, Issue 8, 1998, Pages 781-785

  Karthaus, M ^a   Rosenthal, C ^a   Huebner, G ^a   Paul, H ^a   Elser, C ^a   Hertenstein, B ^a   Krauter, J ^a   Scharmann, T ^a   Geissler, R G ^a   Heil, G ^a   Ganser, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

High grade lymphoma; Oral mucositis; Randomised trial; Topical G CSF

Indexed keywords

ANTIINFECTIVE AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DYSPHAGIA; ERYTHEMA; FEMALE; HOSPITALIZATION; HUMAN; LYMPHOMA; MALE; MOUTH HYGIENE; MOUTH ULCER; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0031794084     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701434     Document Type: Article

References (21)

1. Sonis ST, Sonis AL, Lieberman A. Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc 1978; 97: 468-472.
2. Ayash LJ, Elias A, Wheeler C et al. Double dose-intensive chemotherapy with autologous marrow and peripheral blood progenitor cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 1994; 12: 27-44.
3. Sonis ST, Costa JW, Evitts SM et al. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992; 7: 49-55.
4. Hughes WT, Armstrong D, Bodey GP et al. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-396.
5. Bergmann OJ. Oral infections and septicemia in immunocompromised patients with hematologic malignancies. J Clin Microbiol 1988; 26: 2105-2109.
6. Kenny SA. Effect of two oral protocols on the incidence of stomatitis in haematology patients. Cancer Nurs 1990; 13: 345-353.
7. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
8. Vogler W, Huguley C, Kerr W. Toxicity and antitumour effect of divided doses of methotrexate. Arch Intern Med 1965; 11: 5285-5293.
9. Mahood D, Dose AM, Loprinzi C. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991; 9: 449-452.
10. Clark PI, Selvin ML. Allopurinol mouthwash and 5-fluorouracil induced oral toxicity. Eur J Surg Oncol 1985; 11: 267-268.
11. Hoelzer D, Ludwig WD, Thiel E et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495-508.
12. Weite K, Reiter A, Mempel K et al. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood 1996; 87: 3143-3150.
13. Lieschke GJ, Ramenghi U, O'Connor MP et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 1992; 82: 589-595.
14. Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. New Engl J Med 1998; 318: 1414-1422.
15. Groopman JE. Status of colony-stimulating factors in cancer and AIDS. Semin Oncol 1990; 17 (Suppl. 1): 31-37.
16. Katano M, Nakamura M, Matsuo T et al. Effect of granulocyte colony-stimulating factor on chemotherapy induced oral mucositis. Surg Today 1995; 25: 202-206.
17. Chi KH, Chen CH, Chan WK et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy. J Clin Oncol 1995; 13: 2620-2628.
18. Spiekermann K, Emmendoerffer A, Elsner J et al. Altered surface marker expression and function of G-CSF induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 1994; 87: 31-38.
19. Peto R, Peto J. Asymptotically efficient rank invariation test procedures (with discussion). JR Stat Soc A 1972; 135: 185-207.
20. Prentice RL. Linear rank tests with right censored data. Biometrika 1978; 65: 167-179.
21. Cartee L, Petros WP, Rosner GL et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. Cytokine 1995; 7: 471-477.